albuterol has been researched along with Peripheral Vascular Diseases in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kals, J | 1 |
Kampus, P | 1 |
Kals, M | 1 |
Pulges, A | 1 |
Teesalu, R | 1 |
Zilmer, M | 1 |
1 other study available for albuterol and Peripheral Vascular Diseases
Article | Year |
---|---|
Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease.
Topics: Adrenergic beta-Agonists; Albuterol; Aorta; Arterial Occlusive Diseases; Arteries; Blood Flow Veloci | 2006 |